BridgeBio Pharma Inc (BBIO)
25.48
+2.07
(+8.84%)
USD |
NASDAQ |
Nov 01, 16:00
25.46
-0.02
(-0.08%)
After-Hours: 20:00
BridgeBio Pharma Max Drawdown (5Y): 92.80% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.80% |
| September 30, 2024 | 92.80% |
| August 31, 2024 | 92.80% |
| July 31, 2024 | 92.80% |
| June 30, 2024 | 92.80% |
| May 31, 2024 | 92.80% |
| April 30, 2024 | 92.80% |
| March 31, 2024 | 92.80% |
| February 29, 2024 | 92.80% |
| January 31, 2024 | 92.80% |
| December 31, 2023 | 92.80% |
| November 30, 2023 | 92.80% |
| October 31, 2023 | 92.80% |
| September 30, 2023 | 92.80% |
| August 31, 2023 | 92.80% |
| July 31, 2023 | 92.80% |
| June 30, 2023 | 92.80% |
| May 31, 2023 | 92.80% |
| April 30, 2023 | 92.80% |
| March 31, 2023 | 92.80% |
| February 28, 2023 | 92.80% |
| January 31, 2023 | 92.80% |
| December 31, 2022 | 92.80% |
| November 30, 2022 | 92.80% |
| October 31, 2022 | 92.80% |
| Date | Value |
|---|---|
| September 30, 2022 | 92.80% |
| August 31, 2022 | 92.80% |
| July 31, 2022 | 92.80% |
| June 30, 2022 | 92.80% |
| May 31, 2022 | 92.80% |
| April 30, 2022 | 89.85% |
| March 31, 2022 | 89.85% |
| February 28, 2022 | 89.85% |
| January 31, 2022 | 87.63% |
| December 31, 2021 | 84.27% |
| November 30, 2021 | 65.45% |
| October 31, 2021 | 65.45% |
| September 30, 2021 | 65.45% |
| August 31, 2021 | 65.45% |
| July 31, 2021 | 65.45% |
| June 30, 2021 | 65.45% |
| May 31, 2021 | 65.45% |
| April 30, 2021 | 65.45% |
| March 31, 2021 | 65.45% |
| February 28, 2021 | 65.45% |
| January 31, 2021 | 65.45% |
| December 31, 2020 | 65.45% |
| November 30, 2020 | 65.45% |
| October 31, 2020 | 65.45% |
| September 30, 2020 | 65.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
44.53%
Minimum
Nov 2019
92.80%
Maximum
May 2022
79.63%
Average
91.33%
Median
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 42.46% |
| Pfizer Inc | 54.78% |
| Vertex Pharmaceuticals Inc | 41.60% |
| PTC Therapeutics Inc | 73.78% |
| Bristol-Myers Squibb Co | 47.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -15.72 |
| Beta (5Y) | 1.089 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.64% |
| Historical Sharpe Ratio (5Y) | -0.0197 |
| Historical Sortino (5Y) | -0.0356 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.41% |